Literature DB >> 3864231

Cytochemical, immunological and ANAE-isoenzyme studies in acute myelomonocytic leukaemia: a study of 39 cases.

C S Scott, M Morgan, H J Limbert, I D MacKarill, B E Roberts.   

Abstract

This study reports the cytochemical, electrophoretic and immunological characteristics of blasts cells from 39 cases of acute myelomonocytic leukaemia (M4). The results indicate considerable cytochemical heterogeneity, particularly with respect to esterase (alpha naphthyl acetate and chloroacetate) activities and suggest that an increased serum lysozyme concentration is a more consistent feature. Investigations with a range of monoclonal antibodies also revealed some differences in expression of monocyte-associated determinants although it is considered that immunological assessments are more consistent than cytochemistry in the detection of monocytic blast cell components. Analysis of ANAE isoenzymes by isoelectric focusing was found to be of particular value in cases where interpretation of ANAE cytochemistry was difficult.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3864231     DOI: 10.1111/j.1600-0609.1985.tb01707.x

Source DB:  PubMed          Journal:  Scand J Haematol        ISSN: 0036-553X


  4 in total

1.  Diagnostic application of monoclonal antibody KB90 (CD11c) in acute myeloid leukaemia.

Authors:  P S Master; S J Richards; J Kendall; B E Roberts; C S Scott
Journal:  Blut       Date:  1989-09

2.  Serum enzyme concentrations in untreated acute myeloid leukaemia.

Authors:  C S Scott; M Davey; A Hamilton; D R Norfolk
Journal:  Blut       Date:  1986-05

3.  TdT expression in acute myeloid leukaemia. Haemopoietic immaturity or maturational asynchrony?

Authors:  A N Stark; I D MacKarill; H J Limbert; P Evans; C S Scott
Journal:  Blut       Date:  1988-01

4.  Prognostic factors and survival in chronic myelomonocytic leukaemia (CMML).

Authors:  A N Stark; J Thorogood; C Head; B E Roberts; C S Scott
Journal:  Br J Cancer       Date:  1987-07       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.